Ribavirin for the treatment of Lassa fever: A systematic review and meta-analysis
Top Cited Papers
Open Access
- 1 October 2019
- journal article
- review article
- Published by Elsevier BV in International Journal of Infectious Diseases
- Vol. 87, 15-20
- https://doi.org/10.1016/j.ijid.2019.07.015
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Mortality Among Confirmed Lassa Fever Cases During the 2015–2016 Outbreak in NigeriaAmerican Journal of Public Health, 2018
- Determining Ribavirin’s mechanism of action against Lassa virus infectionScientific Reports, 2017
- Constraints in the diagnosis and treatment of Lassa Fever and the effect on mortality in hospitalized children and women with obstetric conditions in a rural district hospital in Sierra LeoneTransactions of the Royal Society of Tropical Medicine and Hygiene, 2014
- Containing a Lassa fever epidemic in a resource-limited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January–March 2012)International Journal of Infectious Diseases, 2013
- Molecular Diagnostics for Lassa Fever at Irrua Specialist Teaching Hospital, Nigeria: Lessons Learnt from Two Years of Laboratory OperationPLoS Neglected Tropical Diseases, 2012
- Hospital‐based surveillance for Lassa fever in Edo State, Nigeria, 2005–2008Tropical Medicine & International Health, 2012
- Review of the Literature and Proposed Guidelines for the Use of Oral Ribavirin as Postexposure Prophylaxis for Lassa FeverClinical Infectious Diseases, 2010
- Risk Maps of Lassa Fever in West AfricaPLoS Neglected Tropical Diseases, 2009
- Treatment of Late Stage Disease in a Model of Arenaviral Hemorrhagic Fever: T-705 Efficacy and Reduced Toxicity Suggests an Alternative to RibavirinPLOS ONE, 2008
- Lassa Fever in the Eastern Province of Sierra Leone, 1970–1972The American Journal of Tropical Medicine and Hygiene, 1974